October 29, 2024 01:25 PM EDT
Manufacturing

Mil­li­pore­Sig­ma in­vests €70M to triple ADC man­u­fac­tur­ing at US site 

Anna Brown

News Reporter

Mer­ck KGaA, through its life sci­ence arm Mil­li­pore­Sig­ma, is again in­creas­ing its man­u­fac­tur­ing foot­print for AD­Cs, this time by al­lo­cat­ing €70 mil­lion ($75.6 mil­lion) to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Bris­tol My­ers re­veals more job cuts in New Jer­sey

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Min­neso­ta 340B rev­enue dri­ven by hos­pi­tals and high-priced drugs, first state re­port says

A service from the Financial Times